| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34099515 |
| PharmacoGx | BRD-K34099515 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CES4A | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | SGSM1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | CPLX2 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0006 |
| mRNA | ZBTB40 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0006 |
| mRNA | RP11-69A21.2 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
| mRNA | VEGFD | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | LINS1 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | TNIP1 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.0007 |
| mRNA | KRTAP4-4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | RAD21L1 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0009 |
